BIO-Europe Spring 2019: Finally, Paion Teeters On Cusp Of Commercialization
Executive Summary
Wolfgang Söhngen, CEO and founder of Paion, discusses the company’s anesthetic/sedative, remimazolam, which has been filed for approval in China, Japan and the US, as well as broader business strategies.